Vladimir B.
- Country
- Croatia
- Department
- Internal Medicine
Research Overview
- Long-term Safety, Tolerability, and Efficacy of Balinatunfib in Adults with Crohn's Disease or Ulcerative Colitis: A Multicenter Extension Study
- A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderately to Severely Active Ulcerative Colitis
- Long‑Term Safety and Efficacy of SPY001‑001 Monotherapy and Combination Therapy with Long‑Acting Antibodies in Adults with Ulcerative Colitis
Data & Insights
Has run more than one trial at 431 of 661 partner sites.
Specializations
Inflammatory Bowel Disease (IBD) Research
This investigator specializes in studying advanced therapeutic approaches for inflammatory bowel diseases, with particular focus on both Crohn's disease and ulcerative colitis.
- Moderately to Severely Active Crohn's Disease Management
- Ulcerative Colitis Treatment Innovation
- Novel Therapeutic Compounds Assessment
Clinical research encompasses evaluation of novel biological agents and targeted therapies for IBD treatment.
Gastrointestinal Immunology
Focused on investigating immunological mechanisms in gastrointestinal disorders, particularly in celiac disease and related autoimmune conditions.
- Celiac Disease Symptom Management
- Gluten-Free Diet Resistance
- Gastrointestinal Immune Response
Research includes evaluation of therapeutic interventions for persistent celiac disease symptoms despite dietary management.
Treatment Innovation
Specializes in evaluating novel therapeutic compounds and biological agents for gastrointestinal disorders.
- Induction Therapy Development
- Maintenance Treatment Strategies
- Comparative Treatment Efficacy
Investigates both established and emerging treatment modalities for chronic gastrointestinal conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.